Answers are grounded in this paper and cite their sources.
Optimized Ni2CoS4 structures demonstrate enhanced antimicrobial and anticancer efficacy, suggesting novel therapeutic options.
The global rise of multidrug-resistant infections and cancer underscores the need for multifunctional therapeutic platforms. This study presents the synthesis, optimization, and biomedical assessment of sonicated hierarchical Ni₂CoS₄ structures, with sample N3 identified as optimal among seven hydrothermally synthesized formulations. N3 exhibited uniform morphology, high crystallinity, and redox-active architecture, as confirmed by XRD, SEM, TEM, and BET (8.19 m²/g). Piezocatalytic performance, assessed via methylene blue degradation, showed 88.57% removal within 4 min under 200 W ultrasonication, alongside a 13.27-fold increase in singlet oxygen and superoxide generation. N3 displayed potent antibacterial activity against MDR Staphylococcus aureus and XDR Pseudomonas aeruginosa, with minimum inhibitory concentrations as low as 5 µg/mL and complete bacterial clearance within 48 h. ROS-mediated membrane disruption and > 99% biofilm eradication were confirmed by DiBAC₄(3), TEM, and comparative assays with non-sonicated controls. In colorectal cancer (HCT-116) models, N3 induced dose-dependent cytotoxicity (IC₅₀ = 100 µg/mL; 91% cell death at LC₅₀) with sustained effects over 96 h. These findings position N3 as a promising ROS-generating platform with dual antimicrobial and anticancer efficacy.
No takes yet. Share an insight, caveat, or question.
Qurbani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: